As cell and gene therapies offer newfound hope to patients, the journey to commercialization is fraught with obstacles. The need for greater efficiency, improved safety, and inventive approaches to pricing and access is paramount. Tackling these challenges was the motivation behind Cell & Gene Day 2023.
Hosted by Endpoints News and co-sponsored by Precision ADVANCE, Center for Breakthrough Medicines, and Alliance for Regenerative Medicine, Cell & Gene Day 2023 showed us the most recent insights on cell and gene therapy research, development, manufacturing, and commercialization.
Through six panel discussions, we explored topics together with accomplished experts from across the advanced therapy field, including representatives from the University of Pennsylvania, Blackstone, Alliance for Regenerative Medicine (ARM), Iovance Biotherapeutics, Spark Therapeutics, Kate Therapeutics, RegenXBio, and more.
Rob Maiale is a leading content strategist and creator with more than 15 years of experience in healthcare marketing and brand development. His specialties include pharma, diagnostics, med-tech, patient education, translational research, and clinical development.
Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.
